JP2025509605A5 - - Google Patents
Info
- Publication number
- JP2025509605A5 JP2025509605A5 JP2024554856A JP2024554856A JP2025509605A5 JP 2025509605 A5 JP2025509605 A5 JP 2025509605A5 JP 2024554856 A JP2024554856 A JP 2024554856A JP 2024554856 A JP2024554856 A JP 2024554856A JP 2025509605 A5 JP2025509605 A5 JP 2025509605A5
- Authority
- JP
- Japan
- Prior art keywords
- independently
- alkyl
- oligonucleotide
- compound
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263320689P | 2022-03-16 | 2022-03-16 | |
| US63/320,689 | 2022-03-16 | ||
| PCT/IB2023/052532 WO2023175536A1 (en) | 2022-03-16 | 2023-03-15 | Lipid monomers for therapeutic delivery of rna |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025509605A JP2025509605A (ja) | 2025-04-11 |
| JP2025509605A5 true JP2025509605A5 (https=) | 2026-03-24 |
Family
ID=85781906
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024554856A Pending JP2025509605A (ja) | 2022-03-16 | 2023-03-15 | Ｒｎａの治療的送達のための脂質モノマー |
Country Status (7)
| Country | Link |
|---|---|
| JP (1) | JP2025509605A (https=) |
| KR (1) | KR20240164787A (https=) |
| CN (1) | CN119213004A (https=) |
| AU (1) | AU2023236844A1 (https=) |
| CA (1) | CA3255238A1 (https=) |
| MX (1) | MX2024011339A (https=) |
| WO (1) | WO2023175536A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2025541262A (ja) * | 2022-12-13 | 2025-12-18 | 上海拓界生物医薬科技有限公司 | 親油性モノマーを含むオリゴヌクレオチド及びその非肝臓送達における使用 |
| AU2024351190A1 (en) * | 2023-09-26 | 2026-03-26 | Tuojie Biotech (Shanghai) Co., Ltd. | Lipid-modified nucleic acid compound, and preparation method and use therefor |
| WO2025261376A1 (zh) * | 2024-06-21 | 2025-12-26 | 北京炫景瑞医药科技有限公司 | 肝外递送配体及其缀合物 |
| WO2026046355A1 (zh) * | 2024-08-31 | 2026-03-05 | 齐鲁制药有限公司 | dsRNA分子、药物组合物及其在肝外递送中的应用 |
| CN119241620B (zh) * | 2024-12-03 | 2025-04-08 | 羿美诚健(上海)生物医药有限公司 | 一种双链siRNA及其制备方法，药物组合物和用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3368933D1 (en) * | 1982-09-21 | 1987-02-12 | Fujisawa Pharmaceutical Co | Phosphate derivatives, process for preparation thereof and pharmaceutical compositions of the same |
| EP3983077A4 (en) * | 2019-06-17 | 2023-12-20 | Alnylam Pharmaceuticals, Inc. | DELIVERY OF OLIGONUCLEOTIDES TO THE STRIATUM |
| KR20230061389A (ko) * | 2020-08-04 | 2023-05-08 | 다이서나 파마수이티컬, 인크. | 올리고뉴클레오티드의 전신 전달 |
-
2023
- 2023-03-15 KR KR1020247033946A patent/KR20240164787A/ko active Pending
- 2023-03-15 CA CA3255238A patent/CA3255238A1/en active Pending
- 2023-03-15 JP JP2024554856A patent/JP2025509605A/ja active Pending
- 2023-03-15 AU AU2023236844A patent/AU2023236844A1/en active Pending
- 2023-03-15 WO PCT/IB2023/052532 patent/WO2023175536A1/en not_active Ceased
- 2023-03-15 CN CN202380040780.XA patent/CN119213004A/zh active Pending
-
2024
- 2024-09-13 MX MX2024011339A patent/MX2024011339A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025509605A5 (https=) | ||
| JP7453269B2 (ja) | 核酸のデリバリーのための新規脂質および脂質ナノ粒子製剤 | |
| US8168605B2 (en) | Polymeric oligonucleotide prodrugs | |
| AU2006297375C1 (en) | Oligonucleotide analogues incorporating 5-aza-cytosine therein | |
| AU678628B2 (en) | Oligonucleotide modulation of multidrug resistance-associated protein | |
| CN114681621B (zh) | 肽寡核苷酸缀合物 | |
| US20070270359A1 (en) | Nucleic Acid-Based Compounds and Methods of Use Thereof | |
| JP2023134433A (ja) | 新規なカルボニル脂質、および核酸を送達するための脂質ナノ粒子製剤 | |
| AU2007303205A1 (en) | Lipid containing formulations | |
| JP5087924B2 (ja) | ガラクトース誘導体、薬物担体及び医薬組成物 | |
| CN118647599A (zh) | 用于脂质纳米颗粒的氟代阳离子脂质 | |
| CN116348150A (zh) | 用于递送治疗剂的脂质缀合物 | |
| EP0911400A1 (en) | Antisense compounds to cd14 | |
| CN116003494A (zh) | 具有核苷酸类似物的双链rna | |
| US6017895A (en) | Oligonucleotides possessing zwitterionic moieties | |
| RU2024129461A (ru) | Липидные мономеры для терапевтической доставки рнк | |
| UA48150C2 (uk) | Похідні амінокислот або аміноспиртів, олігонуклеотид | |
| FR2534808A1 (fr) | Composition antivirale contenant du 2-(4-chlorophenoxymethyl)-3,3-dimethyl-1-(1,2,4-triazole-1-yl)-2-butanol | |
| IE913321A1 (en) | Compositions and methods for inhibiting growth or¹replication of microbes, viruses and self-replicating¹nucleic acids | |
| AU2020202816B2 (en) | Lipid containing formulations | |
| JP2024508780A5 (https=) | ||
| WO2022250072A1 (ja) | 心疾患治療薬 | |
| JP5496232B2 (ja) | Ｉｌ−８発現抑制剤 | |
| JPWO2020262555A5 (https=) | ||
| SULLIVAN et al. | the 5'TAT Splice Acceptor Site |